Previous studies have shown that luteolin, an antioxidant and anti-inflammatory agent 12, could upregulate the expression of pro-apoptotic caspase-3 to induce cell death in breast cancer MDA-MB-231 cells 27. This evidence concerns the gene CASP3 and breast carcinoma.